loaderimg
image

Respinova has developed a novel non-invasive technology, PulseHaler, that aims to treat the core of COPD pathophysiology. COPD is projected to be the world’s 3rd leading cause of death by 2020, affecting 5-10% of the population. We are also applying our technology to improve the delivery of inhaled drugs.

Company’s Keywords:

Q How Many Employees Does This Company Have?

<3

Q Which Industry Does This Company Belong To?

Q What Is the Annual Income?

<

Q What Is the Technology of All the Company’s Website?

Q What Year Was the Company Founded?

<2008

Rate us and Write a Review

Your review is recommended to be at least 140 characters long

image

building Own or work here? Claim Now! Claim Now!

imageYour request has been submitted successfully.

image